Oncology Specialties, Alabama Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2003
NCT00225056
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now